1. Home
  2. JOUT vs NGNE Comparison

JOUT vs NGNE Comparison

Compare JOUT & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JOUT

Johnson Outdoors Inc.

HOLD

Current Price

$45.99

Market Cap

456.3M

ML Signal

HOLD

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$34.90

Market Cap

744.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOUT
NGNE
Founded
1970
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.3M
744.9M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
JOUT
NGNE
Price
$45.99
$34.90
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$63.57
AVG Volume (30 Days)
47.0K
310.4K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
2.53%
N/A
EPS Growth
N/A
0.93
EPS
N/A
N/A
Revenue
$592,415,000.00
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.78
$15.93
52 Week High
$53.54
$43.66

Technical Indicators

Market Signals
Indicator
JOUT
NGNE
Relative Strength Index (RSI) 53.54 47.61
Support Level $43.00 $18.24
Resistance Level $48.02 $37.27
Average True Range (ATR) 1.35 3.04
MACD 0.20 -0.65
Stochastic Oscillator 74.27 17.67

Price Performance

Historical Comparison
JOUT
NGNE

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: